Houston, TX – February 3, 2012 – Genentech announced that Erivedge ™ (vismodegib) capsule was approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with basal cell carcinoma (BCC, a type of skin cancer.) Erivedge™ was approved on January 30, 2012.
Dr. Leonard H. Goldberg,… Read More
New treatments have been approved for for both actinic keratoses and basal cell carcinoma. From Skin and Allergy News:
“The Food and Drug Administration approved two strengths of ingenol mebutate gel for the treatment of actinic keratoses Jan. 23.
The 0.015% formulation of ingenol mebutate gel (Picato) was
… Read More